University of British Columbia
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, University of British Columbia sits in the top decile of US sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count).
University of British Columbia: 18 sponsored US clinical trials, 6 recruiting.
University of British Columbia sponsors 18 registered US clinical trials on ClinicalTrials.gov, 6 of them currently recruiting, and 8 completed. 2 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Aortic Stenosis, with 2 trials.
Top-decile sponsor footprint
University of British Columbia ranks in the top decile of sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
8 of 10 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
18 total, page 1 of 1
Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.
NCT07292558
Smart Discharges for Older Children
NCT07629154
St. Paul's Advanced Resection Center Cohort for Colorectal Neoplasia (SPARC-C)
NCT05402696
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
NCT04812366
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
NCT04634240
Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates
NCT03674307
HEARTBiT: Multi-Marker Blood Test for Acute Cardiac Transplant Rejection
NCT03575910
Single-dose Prophylactic INdomethacin in Extremely Preterm Infants
NCT06572917
Standardized Invasive Hemodynamics for Elevated Gradients Post TAVR (DISCORDANCE TAVR)
NCT04827238
Gastrointestinal and Urinary Tract Microbiome After SCI
NCT02903472
Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock
NCT01867905
Plasma Injections Plus Exercise for Patellar Tendinopathy
NCT02116946
The Canadian Multicentre CSF Monitoring and Biomarker Study
NCT01279811
Seprafilm™ for the Prevention of Intraperitoneal Adhesions and Improved Delivery of Therapy in Women Undergoing Staging and Intraperitoneal Chemotherapy for Advanced Ovarian Cancer
NCT01095367
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
NCT01192412
Multicenter Study of Antiarrhythmic Medications for Treatment of Infants With Supraventricular Tachycardia
NCT00390546
Genetic Linkage Study of Idiopathic Talipes Equinovarus (ITEV) (Clubfoot)
NCT00474344
Secondary Prevention of Small Subcortical Strokes Trial
NCT00059306
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 3 | 2 |
What is open in the University of British Columbia pipeline
6 recruiting of 18 indexed (33% open); 8 completed (44%).
Phase mix: 2 late (III/IV) vs 3 early (I/II) (balanced across stages).
Top condition: Aortic Stenosis (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of British Columbia: open-pipeline peers nationwide
Peers matched on 18 registered trials and 33% open enrollment, not the therapeutic-area sidebar.
University of British Columbia sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 18 trials (± recruiting share)
- ADC Therapeutics S.A. · 18 trials · 11% recruiting
- Akros Pharma · 18 trials · 0% recruiting
- AO Clinical Investigation and Publishing Documentation · 18 trials · 0% recruiting
- AO Innovation Translation Center · 18 trials · 33% recruiting
Sponsors near 33% open enrollment (± trial volume)
- Aadi Bioscience · 33% recruiting · 9 trials
- Aaron Cook · 33% recruiting · 3 trials
- Abivax S.A. · 33% recruiting · 6 trials
- Actuated Medical · 33% recruiting · 3 trials
Related
What to do with this University of British Columbia page
18 registered trials is a research-attention snapshot, not an endorsement of University of British Columbia or any single study.
- 6 of University of British Columbia's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Aortic Stenosis is the condition University of British Columbia studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Aortic Stenosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of British Columbia pipeline card: 18 registered trials from official public datasets.Report a data error.